Sterrebeek, Belgium

Franck Verschuren

This inventor holds 1 USPTO granted patent. Top assignee: General Electric Company. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franck Verschuren. Retrieved from https://idiyas.com/inventor/franck-verschuren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franck Verschuren: Innovator in Pulmonary Embolism Detection

Introduction

Franck Verschuren is a notable inventor based in Sterrebeek, Belgium. He has made significant contributions to the field of medical technology, particularly in the detection of pulmonary embolism.

Latest Patents

Verschuren holds a patent for a method and apparatus designed to indicate the absence of a pulmonary embolism in a patient. This innovative approach involves measuring the partial pressure of carbon dioxide (PCO) during the expiration of breathing gases. It also includes assessing the end-tidal carbon dioxide (EtCO) and the blood carbon dioxide partial pressure (PaCO). By analyzing the relationship between changes in breathing gas PCO and the volume of expired gases, the method determines whether a pulmonary embolism is present based on a threshold value.

Career Highlights

Franck Verschuren is associated with General Electric Company, where he applies his expertise in medical technology. His work focuses on enhancing diagnostic methods that can lead to better patient outcomes.

Collaborations

He has collaborated with notable colleagues, including Erkki Paavo Heinonen and Rene Johannes Coffeng, contributing to advancements in their respective fields.

Conclusion

Franck Verschuren's innovative work in pulmonary embolism detection exemplifies the impact of technology on healthcare. His contributions continue to pave the way for improved diagnostic methods in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…